{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:10:33Z","timestamp":1790356233304,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutrition"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.tjnut.2023.05.019","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T11:06:53Z","timestamp":1684753613000},"page":"1984-1993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Probiotic Supplementation, Hepatic Fibrosis, and the Microbiota Profile in Patients with Nonalcoholic Steatohepatitis: A Randomized Controlled Trial"],"prefix":"10.1016","volume":"153","author":[{"given":"Giselle S.","family":"Escouto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Z.","family":"Port","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane V.","family":"Tovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina A.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Peres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilson P.","family":"Dorneles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa P.","family":"Houde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault V.","family":"Varin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Pilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Marette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Buss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"40","key":"10.1016\/j.tjnut.2023.05.019_bib1","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.3748\/wjg.v19.i40.6911","article-title":"Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis","volume":"19","author":"Ma","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.tjnut.2023.05.019_bib2","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1464-5491.2005.01748.x","article-title":"Recent concepts in non-alcoholic fatty liver disease","volume":"22","author":"Adams","year":"2005","journal-title":"Diabet. Med."},{"issue":"8","key":"10.1016\/j.tjnut.2023.05.019_bib3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"13-14","key":"10.1016\/j.tjnut.2023.05.019_bib4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.clinbiochem.2015.06.023","article-title":"Gut-liver axis, nutrition, and non-alcoholic fatty liver disease","volume":"48","author":"Kirpich","year":"2015","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.tjnut.2023.05.019_bib5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1210\/er.2009-0030","article-title":"Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk","volume":"31","author":"Manco","year":"2010","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.tjnut.2023.05.019_bib6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/hep.29892","article-title":"Novel link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD Cyrielle","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.tjnut.2023.05.019_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032734","article-title":"Efficacy of probiotics on nonalcoholic fatty liver disease: a meta-analysis","volume":"102","author":"Zhou","year":"2023","journal-title":"Medicine"},{"issue":"15","key":"10.1016\/j.tjnut.2023.05.019_bib8","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.3390\/ijms23158805","article-title":"The effects of probiotics, prebiotics and Synbiotics in non-alcoholic fat liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a systematic review","volume":"23","author":"Carpi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.tjnut.2023.05.019_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1665-2681(19)31246-3","article-title":"Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients","volume":"13","author":"Buss","year":"2014","journal-title":"Ann. Hepatol."},{"issue":"4","key":"10.1016\/j.tjnut.2023.05.019_bib10","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00394-018-1721-2","article-title":"Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial","volume":"58","author":"Bomhof","year":"2019","journal-title":"Eur. J. Nutr."},{"issue":"12","key":"10.1016\/j.tjnut.2023.05.019_bib11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/1751-2980.12561","article-title":"Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: a pilot trial","volume":"18","author":"Manzhalii","year":"2017","journal-title":"J.\u00a0Dig. Dis."},{"issue":"46","key":"10.1016\/j.tjnut.2023.05.019_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/MCG.0b013e3182549092","article-title":"World Gastroenterology Organization Global Guidelines: probiotics and prebiotics October 2011","volume":"80","author":"Guarner","year":"2012","journal-title":"J.\u00a0Clin. Gastroenterol."},{"issue":"6","key":"10.1016\/j.tjnut.2023.05.019_bib13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.mcg.0000165671.25272.0f","article-title":"Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases","volume":"39","author":"Loguercio","year":"2005","journal-title":"J.\u00a0Clin. Gastroenterol."},{"issue":"9","key":"10.1016\/j.tjnut.2023.05.019_bib14","first-page":"1090","article-title":"Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial","volume":"15","author":"Aller","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"suppl 1","key":"10.1016\/j.tjnut.2023.05.019_bib15","first-page":"1","article-title":"Brazilian guidelines on diagnosis and treatment of metabolic syndrome","volume":"84","author":"de Hipertens\u00e3o","year":"2005","journal-title":"Arq. Bras. Cardiol."},{"issue":"24","key":"10.1016\/j.tjnut.2023.05.019_bib16","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/jama.1994.03520240054041","article-title":"A\u00a0proposal for structured reporting of randomized controlled trials","volume":"272","author":"Andrew","year":"1994","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.tjnut.2023.05.019_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/nu9091021","article-title":"Effects of probiotics, prebiotics, and synbiotics on human health","volume":"9","author":"Markowiak","year":"2017","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.tjnut.2023.05.019_bib18","doi-asserted-by":"crossref","first-page":"7386","DOI":"10.3168\/jds.2014-8500","article-title":"Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease","volume":"97","author":"Nabavi","year":"2014","journal-title":"J.\u00a0Dairy Sci."},{"issue":"11","key":"10.1016\/j.tjnut.2023.05.019_bib19","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/apt.12758","article-title":"Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis","volume":"39","author":"Alisi","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"28","key":"10.1016\/j.tjnut.2023.05.019_bib20","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur. Heart J."},{"issue":"suppl 1","key":"10.1016\/j.tjnut.2023.05.019_bib21","first-page":"S5","article-title":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the description of diabetes categories of glucose","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.tjnut.2023.05.019_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1586\/14737159.7.5.481","article-title":"FibroMAX: towards a new universal biomarker of liver disease?","volume":"7","author":"Morra","year":"2007","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"11","key":"10.1016\/j.tjnut.2023.05.019_bib23","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/j.1572-0241.2001.05268.x","article-title":"Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection","volume":"96","author":"Pohl","year":"2001","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.tjnut.2023.05.019_bib24","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.tjnut.2023.05.019_bib25","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.tjnut.2023.05.019_bib26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.tjnut.2023.05.019_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143334","article-title":"Comparative evaluation of DNA extraction methods from feces of multiple host species for downstream next-generation sequencing","volume":"10","author":"Hart","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.tjnut.2023.05.019_bib28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/bioinformatics\/btt593","article-title":"PEAR: a fast and accurate Illumina Paired-End reAd mergeR","volume":"30","author":"Zhang","year":"2014","journal-title":"Bioinformatics"},{"issue":"16","key":"10.1016\/j.tjnut.2023.05.019_bib29","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/bioinformatics\/btr381","article-title":"UCHIME improves sensitivity and speed of chimera detection","volume":"27","author":"Edgar","year":"2011","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.tjnut.2023.05.019_bib30","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/AEM.03006-05","article-title":"Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB","volume":"72","author":"Desantis","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"issue":"16","key":"10.1016\/j.tjnut.2023.05.019_bib31","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1128\/AEM.00062-07","article-title":"Na\u00efve bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy","volume":"73","author":"Wang","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"issue":"6","key":"10.1016\/j.tjnut.2023.05.019_bib32","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome. Biol."},{"key":"10.1016\/j.tjnut.2023.05.019_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.844242","article-title":"Effect of probiotics on liver enzymes in patients with non-alcoholic fatty liver disease: an umbrella of systematic review and meta-analysis","volume":"9","author":"Musazadeh","year":"2022","journal-title":"Front Nutr"},{"issue":"7","key":"10.1016\/j.tjnut.2023.05.019_bib34","first-page":"477","article-title":"APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD\/NASH","volume":"101","author":"Kruger","year":"2011","journal-title":"S.\u00a0Afr. Med. J."},{"issue":"4","key":"10.1016\/j.tjnut.2023.05.019_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/00325481.2022.2058285","article-title":"Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population","volume":"134","author":"Rigor","year":"2022","journal-title":"Postgrad. Med."},{"issue":"5","key":"10.1016\/j.tjnut.2023.05.019_bib36","first-page":"531","article-title":"Effect of a probiotic and metformin on liver aminotransferases in non-alcoholic steatohepatitis: a double blind randomized clinical trial","volume":"4","author":"Shavakhi","year":"2013","journal-title":"Int. J. Prev. Med."},{"issue":"2","key":"10.1016\/j.tjnut.2023.05.019_bib37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1665-2681(19)31364-X","article-title":"Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study","volume":"12","author":"Wong","year":"2013","journal-title":"Ann. Hepatol."},{"issue":"5","key":"10.1016\/j.tjnut.2023.05.019_bib38","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1017\/S0007114517000204","article-title":"Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial","volume":"117","author":"Mofidi","year":"2017","journal-title":"Br. J. Nutr."},{"issue":"2","key":"10.1016\/j.tjnut.2023.05.019_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-011-1887-4","article-title":"Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis","volume":"57","author":"Malaguarnera","year":"2012","journal-title":"Dig. Dis. Sci."},{"issue":"7","key":"10.1016\/j.tjnut.2023.05.019_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu8070397","article-title":"Beneficial effect of synbiotic supplementation on hepatic steatosis and anthropometric parameters, but not on gut permeability in a population with nonalcoholic steatohepatitis","volume":"8","author":"Ferolla","year":"2016","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.tjnut.2023.05.019_bib41","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/MPG.0b013e31821f9b85","article-title":"Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease","volume":"52","author":"Vajro","year":"2011","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"issue":"6","key":"10.1016\/j.tjnut.2023.05.019_bib42","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/07315724.2015.1031355","article-title":"Effects of multistrain probiotic supplementation on glycemic and inflammatory indices in patients with nonalcoholic fatty liver disease: a double-blind randomized clinical trial","volume":"35","author":"Sepideh","year":"2016","journal-title":"J.\u00a0Am. Coll. Nutr."},{"issue":"4","key":"10.1016\/j.tjnut.2023.05.019_bib43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4254\/wjh.v4.i4.110","article-title":"Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease","volume":"4","author":"Yan","year":"2012","journal-title":"World. J. Hepatol."},{"issue":"1","key":"10.1016\/j.tjnut.2023.05.019_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.livres.2017.11.005","article-title":"Gut microbiota, fatty liver disease, and hepatocellular carcinoma","volume":"2","author":"Chu","year":"2018","journal-title":"Liver Res"},{"issue":"7","key":"10.1016\/j.tjnut.2023.05.019_bib45","first-page":"868","article-title":"Obese humans with nonalcoholic fatty liver disease CONCLUSIONS","volume":"11","author":"Raman","year":"2013","journal-title":"YJCGH"},{"key":"10.1016\/j.tjnut.2023.05.019_bib46","first-page":"764","volume":"63","author":"Boursier","year":"2017"},{"issue":"4","key":"10.1016\/j.tjnut.2023.05.019_bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.tjnut.2023.05.019_bib48","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1038\/srep08096","article-title":"Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.tjnut.2023.05.019_bib49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.26319","article-title":"Intestinal microbiota in patients with nonalcoholic fatty liver disease","volume":"58","author":"Mouzaki","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.tjnut.2023.05.019_bib50","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s13679-015-0172-9","article-title":"Gut microbiota dysbiosis in obesity-linked metabolic diseases and prebiotic potential of polyphenol-rich extracts","volume":"4","author":"Anh\u00ea","year":"2015","journal-title":"Curr. Obes. Rep."},{"issue":"1","key":"10.1016\/j.tjnut.2023.05.019_bib51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12876-015-0400-5","article-title":"Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol","volume":"15","author":"Lambert","year":"2015","journal-title":"BMC Gastroenterol"},{"issue":"suppl 1","key":"10.1016\/j.tjnut.2023.05.019_bib52","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/1475-2859-10-S1-S10","article-title":"Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome","volume":"10","author":"Delzenne","year":"2011","journal-title":"Microb. Cell Fact."},{"issue":"1","key":"10.1016\/j.tjnut.2023.05.019_bib53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13073-016-0300-5","article-title":"Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials","volume":"8","author":"Kristensen","year":"2016","journal-title":"Genome. Med."}],"container-title":["The Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316623676126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316623676126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T05:44:59Z","timestamp":1758347099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022316623676126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0022316623676126"],"URL":"https:\/\/doi.org\/10.1016\/j.tjnut.2023.05.019","relation":{},"ISSN":["0022-3166"],"issn-type":[{"value":"0022-3166","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probiotic Supplementation, Hepatic Fibrosis, and the Microbiota Profile in Patients with Nonalcoholic Steatohepatitis: A Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjnut.2023.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of American Society for Nutrition.","name":"copyright","label":"Copyright"}]}}